Drug Type Synthetic peptide |
Synonyms |
Target |
Mechanism α3β4 receptor antagonists(Neuronal acetylcholine receptor; alpha3/beta4 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pain | Preclinical | IN | 01 May 2020 |